ciprofloxacin and alpha-aminopyridine

ciprofloxacin has been researched along with alpha-aminopyridine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akaki, T; Kajitani, H; Sato, K; Shishido, S; Tomioka, H1
Cantón, R; Garcia-Alonso, F; Gargallo-Viola, D; López, Y; Moreno-Bofarull, A; Morosini, MI; Tato, M; Vila, J1
Cantón, R; Espinal, P; Garcia-Alonso, F; Gargallo-Viola, D; López, Y; Tato, M; Vila, J1
Chaiprasert, A; Disratthakit, A; Doi, N; Leechawengwongs, M; Prammananan, T; Thaipisuttikul, I; Tribuddharat, C1
Bauer, D; Chen, J; Chen, Y; Dosik, JS; Kulmatycki, K; Meyers, D; Noe, A; Soon, RL1

Trials

1 trial(s) available for ciprofloxacin and alpha-aminopyridine

ArticleYear
The DGAT1 inhibitor pradigastat does not induce photosensitivity in healthy human subjects: a randomized controlled trial using three defined sunlight exposure conditions.
    Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2016, 08-31, Volume: 15, Issue:9

    Topics: Acetates; Adolescent; Adult; Aminopyridines; Ciprofloxacin; Diacylglycerol O-Acyltransferase; Double-Blind Method; Enzyme Inhibitors; Female; Healthy Volunteers; Humans; Male; Middle Aged; Photosensitizing Agents; Sunlight; Young Adult

2016

Other Studies

4 other study(ies) available for ciprofloxacin and alpha-aminopyridine

ArticleYear
Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:2

    Topics: 4-Quinolones; Aminopyridines; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Rifamycins

2000
Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC values.
    Diagnostic microbiology and infectious disease, 2014, Volume: 78, Issue:3

    Topics: Aminopyridines; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Hydrogen-Ion Concentration; Levofloxacin; Microbial Sensitivity Tests; Quinolones

2014
In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:1

    Topics: Aminopyridines; Anti-Bacterial Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Quinolones; Selection, Genetic; Sequence Analysis, DNA

2015
Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9

    Topics: Aminopyridines; Antitubercular Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Gatifloxacin; Gene Expression; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Thailand; Tuberculosis, Pulmonary

2016